Bavarian Nordic

Danish vaccine leader Bavarian Nordic develops and supplies non‑replicating smallpox/monkeypox, rabies, tick‑borne encephalitis, oral cholera and typhoid vaccines worldwide; expanding with MVA‑BN RSV and anti‑cancer candidates to capture global disease‑prevention markets.

Headquarters: Denmark (DNK)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 1,738
HQ: Hellerup

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
BAVA	Bavarian Nordic Class A/S Cap: 15.5B \| P/E: 6.5	EQUITY	CPH	DKK	DK0015998017	Active	📈